共 50 条
- [2] Lusutrombopag Is a Safe Treatment Option for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Invasive Procedure: Pooled Safety Analysis From 3 Studies [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S585 - S585
- [4] Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures [J]. Hepatology International, 2023, 17 : 180 - 189
- [7] Lusutrombopag for Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Who Are Undergoing Planned Invasive Procedures: Pooled Safety Analysis of Bleeding-Related Adverse Events [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S550 - S550